Plain-English translation of NCT05227053 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is following patients who have received the Arctic Front cardiac cryoablation catheter system—a device that uses freezing to treat an irregular heartbeat condition called paroxysmal atrial fibrillation. Researchers want to understand how well this freezing procedure works over the long term and how safe it is compared to taking heart rhythm medications. You would be part of a global group of about 200 patients being monitored to help answer these questions.
Many people with atrial fibrillation are currently treated with medications to control their heart rhythm, but these drugs don't work for everyone and can cause side effects. This study exists to confirm that the freezing catheter procedure is a safe and effective alternative option for people who haven't had success with or want to avoid long-term medications.
You likely qualify if…
You likely don't qualify if…
You would receive the freezing catheter procedure as your treatment for atrial fibrillation, and then the research team would follow up with you over time to monitor how well the procedure works and whether you experience any side effects. The study is observational, meaning researchers are collecting information from your medical records and visits rather than testing a new investigational medication. You would be part of a global registry tracking long-term outcomes to help doctors understand this treatment better.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States